You are here: Home: NHLU 6 2005 : Craig Moskowitz, MD: Select publications
SELECT PUBLICATIONS
Coiffier B et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002;346(4):235-42. Abstract
Halaas JL et al. R-CHOP-14 in patients with diffuse large B-cell lymphoma: Feasibility and preliminary efficacy. Leuk Lymphoma 2005;46(4):541-7. Abstract
Hans CP et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004;103(1):275- 82. Abstract
Kewalramani T et al. Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma. Blood 2004;103(10):3684-8. Abstract
Moskowitz CH et al. Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL. Blood 2005;106(10):3383-5. Abstract
Norton L, Simon R. The Norton-Simon Hypothesis revisited. Cancer Treat Rep 1986;70(1):163-9. No abstract available
Pfreundschuh M et al; German High-Grade Non-Hodgkin’s Lymphoma Study. Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: Results of the NHL-B2 trial of the DSHNHL. Blood 2004;104(3):634-41. Abstract
Portlock CS et al. The NHL-15 protocol for aggressive non-Hodgkin’s lymphomas: A sequential dose-dense, dose-intense regimen of doxorubicin, vincristine and high-dose cyclophosphamide. Ann Oncol 2004;15(10):1495-503. Abstract
|